The Progestin-Only Contraceptive Medroxyprogesterone Acetate, but Not Norethisterone Acetate, Enhances HIV-1 Vpr-Mediated Apoptosis in Human CD4+ T Cells through the Glucocorticoid Receptor

作者: Michele Tomasicchio , Chanel Avenant , Andrea Du Toit , Roslyn M. Ray , Janet P. Hapgood

DOI: 10.1371/JOURNAL.PONE.0062895

关键词:

摘要: The glucocorticoid receptor (GR) regulates several physiological functions, including immune function and apoptosis. HIV-1 virus accessory protein, viral protein R (Vpr), can modulate the transcriptional response of GR. Glucocorticoids (GCs) Vpr have been reported to induce apoptosis in various cells, T-cells. We previously shown that injectable contraceptive, medroxyprogesterone acetate (MPA) is a partial full agonist for GR, unlike norethisterone (NET-A). investigated functional cross talk between GR inducing CD4+ T-cells, absence presence GCs these progestins, as well progesterone. By using flow cytometry, we show that, contrast NET-A progesterone, synthetic ligand dexamethasone (Dex), cortisol MPA primary Furthermore, C-terminal part peptide, or pseudovirus, together with Dex further increased apoptotic phenotype, combination Western blotting, PCR use receptor- selective agonists, provide evidence estrogen are only steroid receptors expressed peripheral blood mononuclear cells. These results, findings RU486, antagonist, prevents Dex-, MPA- Vpr-mediated apoptosis, first time agonists increase T-cells via induction involves differential expression key genes by both GCs/MPA. This work suggests contraceptive doses but not progesterone could potentially accelerate depletion GR-dependent fashion positive women, thereby contributing immunodeficiency. results imply choice progestin used contraception may be critical susceptibility progression diseases such HIV-1.

参考文章(116)
Mishell Dr, Pharmacokinetics of depot medroxyprogesterone acetate contraception. Journal of Reproductive Medicine. ,vol. 41, pp. 381- 390 ,(1996)
Kimmo Kontula, Timo Paavonen, Tapani Luukkainen, Leif C. Andersson, Binding of progestins to the glucocorticoid receptor Biochemical Pharmacology. ,vol. 32, pp. 1511- 1518 ,(1983) , 10.1016/0006-2952(83)90474-4
Mingzhong Chen, Robert T. Elder, Min Yu, Maurice G. O’Gorman, Luc Selig, Richard Benarous, Ayumu Yamamoto, Yuqi Zhao, Mutational analysis of Vpr-induced G2 arrest, nuclear localization, and cell death in fission yeast. Journal of Virology. ,vol. 73, pp. 3236- 3245 ,(1999) , 10.1128/JVI.73.4.3236-3245.1999
Frank Z. Stanczyk, Pharmacokinetics and potency of progestins used for hormone replacement therapy and contraception. Reviews in Endocrine & Metabolic Disorders. ,vol. 3, pp. 211- 224 ,(2002) , 10.1023/A:1020072325818
Julia C Buckingham, Glucocorticoids: exemplars of multi-tasking. British Journal of Pharmacology. ,vol. 147, ,(2006) , 10.1038/SJ.BJP.0706456
Mette D. Hazenberg, Dörte Hamann, Hanneke Schuitemaker, Frank Miedema, T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock. Nature Immunology. ,vol. 1, pp. 285- 289 ,(2000) , 10.1038/79724
Beverly H. Draper, Chelsea Morroni, Margaret N Hoffman, Jennifer A Smit, Mags E. Beksinska, Janet P. Hapgood, Lize van der Merwe, Depot medroxyprogesterone versus norethisterone oenanthate for long-acting progestogenic contraception. Cochrane Database of Systematic Reviews. ,(2006) , 10.1002/14651858.CD005214.PUB2
Y L Lu, P Spearman, L Ratner, Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions. Journal of Virology. ,vol. 67, pp. 6542- 6550 ,(1993) , 10.1128/JVI.67.11.6542-6550.1993
A Borgne-Sanchez, S Dupont, A Langonné, L Baux, H Lecoeur, D Chauvier, M Lassalle, O Déas, J-J Brière, M Brabant, P Roux, C Péchoux, J-P Briand, J Hoebeke, A Deniaud, C Brenner, P Rustin, L Edelman, D Rebouillat, E Jacotot, Targeted Vpr-derived peptides reach mitochondria to induce apoptosis of alphaVbeta3-expressing endothelial cells. Cell Death & Differentiation. ,vol. 14, pp. 422- 435 ,(2007) , 10.1038/SJ.CDD.4402018